From: Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin
Batch | Particle size (mean ± SD, nm) | Zeta potential (mean ± SD, mV) | Percent drug entrapment (mean ± SD, %) |
---|---|---|---|
SLN 1 | 145 ± 0.57a | 20.7 ± 0.22a | 62.88 ± 0.99 |
156 ± 0.64b | 15.8 ± 0.13b | ||
SLN 2 | 168 ± 0.43a | 20.2 ± 0.17a | 64.21 ± 0.83 |
179 ± 0.27b | 15.4 ± 0.14b | ||
SLN 3 | 218 ± 0.39a | 19.7 ± 0.13a | 67.11 ± 0.42 |
226 ± 0.44b | 14.9 ± 0.11b | ||
SLN 4 | 158 ± 0.55a | 17.5 ± 0.22a | 82.32 ± 0.89 |
165 ± 0.56b | 13.5 ± 0.19b | ||
SLN 5c | 188 ± 0.97a | 16.8 ± 0.33a | 84.99 ± 0.73 |
194 ± 0.89b | 12.43 ± 0.26b | ||
SLN 6 | 221 ± 0.6a | 16.4 ± 0.11a | 85.91 ± 0.64 |
229 ± 0.41b | 12.1 ± 0.17b | ||
SLN 7 | 164 ± 0.41a | 14.3 ± 0.12a | 86.58 ± 0.78 |
172 ± 0.66b | 9.6 ± 0.11b | ||
SLN 8 | 206 ± 0.99a | 13.8 ± 0.099a | 87.22 ± 0.85 |
214 ± 0.75b | 9.3 ± 0.1b | ||
SLN 9 | 228 ± 0.54a | 13.6 ± 0.092a | 89.02 ± 0.66 |
239 ± 0.48b | 8.9 ± 0.098b |